Skip to main content
GENB logo

Generate Biomedicines, Inc.

GENBNASDAQHealthcareBiotechnology

$12.35Today:- (-)

As of Oct 26, 2026 close

Market cap
$1.58B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$11.00$22.67
Volume (live)
-
Avg. volume (3M)
1.06M

Generate Biomedicines, Inc. (GENB) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Generate Biomedicines, Inc. stock.

Analyst Consensus Rating

Investment consensus from 4 professional research analysts

Consensus Rating

Buy
Based on 4 unique analysts
(6 total ratings in last 90 days)
Low Confidence∞:1 Buy/Sell

Average Price Target

$26.00
+110.53% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest GENB Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Edmund Ingham
Forbes
HoldInitiates Coverage
-
Mitchell Kapoor
HC Wainwright
BuyReiterates
$30.00
Edward Tenthoff
Piper Sandler
BuyReiterates
$26.00
Mitchell Kapoor
HC Wainwright
BuyReiterates
$30.00
Edward Tenthoff
Piper Sandler
BuyReiterates
$26.00
Sean Laaman
Morgan Stanley
BuyReiterates
$22.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 14, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for GENB?

The analyst consensus rating for GENB is Buy, based on the latest ratings from 4 analysts over the last 90 days.

What is the average price target for GENB?

The average 12-month price target for GENB is $26.00, representing an upside of 110.5% from the Oct 26, 2026 close of $12.35.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.